Antag Therapeutics

Series-A
antagtx.com Biotech & Healthcare Founded 2017
Total Funding $84M
Latest Round $84M Series-A
Last Announced Dec 4, 2024
Investors Undisclosed
Decision Makers Profile Active

About Antag Therapeutics

Develops GIP receptor antagonist therapies for obesity and diabetes.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Year Founded 2017
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website antagtx.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $84,000,000 · Series-A

    startupintros.com

  2. Milestone

    Company founded

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Antag Therapeutics.

Funding History

1 Round
Series-A equity · Dec 4, 2024

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts